Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

被引：0
|
作者：
Gozel, Sedat [1 ]
Sumbul, Ahmet [1 ]
Sedef, Ali Murat [1 ]
Besen, Ayberk [1 ]
Mertsoylu, Huseyin [1 ]
Batmaci, Celal [2 ]
Kose, Fatih [3 ]
机构：
[1] Baskent Univ, Adana, Turkey
[2] Hakkari Devlet Hastanesi, Hakkari, Turkey
[3] Baskent Univ, Med Oncol, Adana, Turkey
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
creatinine clearance; small cell lung cancer; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-010
引用
收藏
页码：S701 / S702
页数：2
相关论文
共 50 条
  • [21] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
    Le Chevalier, T
    Arriagada, R
    Le Péchoux, C
    Grunenwald, D
    Dunant, A
    Pignon, JP
    Tarayre, M
    Abratt, R
    Arriagada, R
    Bergman, B
    Gralla, R
    Grunenwald, D
    Le Chevalier, T
    Orlowski, T
    Papadakis, E
    Pinel, MIS
    Araujo, C
    Della Torre, H
    de Solchaga, MM
    Abdi, E
    Blum, R
    Ball, D
    Basser, R
    De Boer, R
    Bishop, J
    Brigham, B
    Davis, S
    Fox, D
    Richardson, G
    Wyld, D
    Pirker, R
    Humblet, Y
    Delaunois, L
    Van Meerbeeck, JP
    Germonpre, P
    Vansteenkiste, J
    Nackaerts, K
    Pinel, MIS
    Vauthier, G
    Younes, RN
    Arriagada, R
    Baeza, R
    Carvajal, P
    Kleinman, S
    Orlandi, L
    Castro, C
    Godoy, J
    Kosatova, K
    Gaafar, R
    Azarian, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04): : 351 - 360
  • [22] Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
    Lee, Yun-Gyoo
    Lee, Eunyoung
    Kim, Inho
    Lee, Keun-Wook
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 670 - 675
  • [23] MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer
    Fouret, P.
    Planchard, D.
    Mendiboure, J.
    Kamal, N. S.
    Olaussen, K. A.
    Bertrand, P.
    Pirker, R.
    Dunant, A.
    Le Chevalier, T.
    Soria, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [24] MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer
    Fouret, P.
    Planchard, D.
    Mendiboure, J.
    Kamal, N. S.
    Olaussen, K. A.
    Bertrand, P.
    Pirker, R.
    Dunant, A.
    Le Chevalier, T.
    Soria, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Yeon Hee
    Kim, Bong-Seog
    Kim, Tae-You
    Im, Young-Hyuck
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 301 - 307
  • [26] Advanced stage non small cell lung cancer patients treated with cisplatin-based chemotherapy doublets: Role of positron emission tomography
    Gebbia, Vittorio
    Ficola, Umberto
    Arrivas, Eugenia Bajardi
    Mancuso, Gianfranco
    Agueli, Zafarana Elena Roberta
    Testa, Antonio
    Borsellino, Nicolo
    ANNALS OF ONCOLOGY, 2005, 16 : 20 - 20
  • [27] Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
    Ota, Shuji
    Ishii, Genichiro
    Goto, Koichi
    Kubota, Kaoru
    Kim, Young Hak
    Kojika, Masakazu
    Murata, Yukinori
    Yamazaki, Manabu
    Nishiwaki, Yutaka
    Eguchi, Kenji
    Ochiai, Atsushi
    LUNG CANCER, 2009, 64 (01) : 98 - 104
  • [28] Mobile aortic mural thrombus in a patient with small-cell lung cancer receiving cisplatin-based chemotherapy
    Borodzicz-Jazdzyk, Sonia
    Fojt, Anna
    Vloka, Monika
    Szczerba, Ewa
    Budnik, Monika
    Grabowski, Marcin
    Opolski, Grzegorz
    Kowalik, Robert
    KARDIOLOGIA POLSKA, 2022, 80 (03) : 376 - 377
  • [29] Histologic subtypes of bladder cancer influence overall survival of patients treated by radical cystectomy and adjuvant cisplatin-based chemotherapy
    Keck, B.
    Taubert, H.
    Wach, S.
    Stoehr, R.
    Kunath, F.
    Bertz, S.
    Lehmann, J.
    Stoeckle, M.
    Hartmann, A.
    Wullich, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E868 - U828
  • [30] Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: Simply a bad combination? Reply
    Herbst, RS
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 930 - 931
12345